increasing dose of tirzepatide Can you take every 5 days? What the pharmacology actually says Tirzepatide (Mounjaro) for the Treatment

While GLP-1 RAs are powerful tools, preoperative use does not consistently translate into superior long-term postoperative weight loss

Learn how Tirzepatide can boost testosterone and weight loss

Analgesic Outcome: Boosts -endorphin release, which binds -opioid receptors on dorsal horn neurons - reducing hypersensitivity without tolerance or addiction risks

The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 28.7% weight loss at 68 weeks Reduced key cardiometabolic risk markers non-HDL cholesterol, triglycerides, and hsCRP Highest dose lowered systolic BP by 14 mmHg Reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function GI side effects most common adverse event We now await 7 additional phase 3 trials in other obesity related comorbidities